Cancer Therapy

Merck and Moffitt Cancer Center announce personalized cancer medicine initiative

Published in Lab Law Weekly, January 19th, 2007

Florida-based H. Lee Moffitt Cancer Center & Research Institute will partner with Merck & Co., Inc. to expand its efforts in research and biotech with the goal of developing personalized medicine to treat cancer.

This multi-site project involves collecting thousands of tumor tissues and clinical data from patients from across the state of Florida. Moffitt will utilize sophisticated technology with Merck to analyze each patient's tumor to identify its genetic "fingerprints" or markers specific to that tumor. By studying and comparing patient's response to specific treatments, scientists will be able to identify drugs that will give physicians the knowledge they need to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-01-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry